Safety and Efficacy of Low-dose IL-2 in Allergy to Birch Pollen

Conditions:   Allergic Rhinoconjunctivitis to Birch Pollen;   With an Apple Oral Allergic Syndrome (OAS) to Apple;   With a Positive Skin Prick Test to Birch Pollen Intervention:   Drug: ILT-101 ld-(IL2) Sponsors:   Assistance Publique - Hôpitaux de Paris;   Iltoo Pharma Not yet recruiting (Source: ClinicalTrials.gov)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2Tf9ZSh